# Congressman Demands DOJ Update on Marijuana Rescheduling > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/marijuana-rescheduling-update-doj-response-pending/ > **Published:** 2026-03-27T15:04:33-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:36:40-04:00 > **Clinical Summary:** Congressman demands marijuana rescheduling update from DOJ, highlighting federal cannabis policy uncertainty and clinical practice impacts. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic PolicyRegulationFederal LawClinical PracticePatient Access Why This Matters Federal rescheduling directly impacts clinical practice by determining research pathways, insurance coverage, and prescribing protocols for [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/). Scheduling delays create ongoing uncertainty for clinicians treating patients with cannabis-responsive conditions. Clinical Summary Congressional pressure for DOJ updates on marijuana rescheduling reflects ongoing federal policy uncertainty three months post-executive order. The current Schedule I classification restricts [clinical research](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/), limits insurance coverage, and creates regulatory barriers for evidence-based [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/). Rescheduling to Schedule III, as previously proposed, would maintain FDA oversight while enabling expanded research and potential insurance coverage for approved cannabis medications. Dr. Caplan’s Take “Policy uncertainty shouldn’t dictate [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-review/) decisions. I continue treating patients based on available evidence while preparing practice protocols for various regulatory scenarios that may emerge.” Clinical Perspective 🧠 Clinicians should maintain current evidence-based practices regardless of scheduling timeline uncertainty. Monitor state-level regulations that directly impact patient access and consider documenting treatment rationales more thoroughly given evolving federal oversight. Prepare patients for potential coverage and access changes without overpromising timeline specifics. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Congressman%20Demands%20Marijuana%20Rescheduling%20Update%20From%20DOJ%2C%20Three%20Months%20After%20....%20%40drcaplan&url=https%3A//www.marijuanamoment.net/congressman-demands-marijuana-rescheduling-update-from-doj-three-months-after-trumps-executive-order/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.marijuanamoment.net/congressman-demands-marijuana-rescheduling-update-from-doj-three-months-after-trumps-executive-order/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Congressman%20Demands%20Marijuana%20Rescheduling%20Update%20From%20DOJ%2C%20Three%20Months%20After%20....%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.marijuanamoment.net/congressman-demands-marijuana-rescheduling-update-from-doj-three-months-after-trumps-executive-order/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.marijuanamoment.net/congressman-demands-marijuana-rescheduling-update-from-doj-three-months-after-trumps-executive-order/](https://www.marijuanamoment.net/congressman-demands-marijuana-rescheduling-update-from-doj-three-months-after-trumps-executive-order/) Table of Contents - [FAQ](#FAQ)[What type of clinical relevance does this cannabis news have?](#What_type_of_clinical_relevance_does_this_cannabis_news_have) - [What areas does this cannabis news cover?](#What_areas_does_this_cannabis_news_cover) - [Why is this news marked as “New”?](#Why_is_this_news_marked_as_8220New8221) - [How does this relate to clinical practice?](#How_does_this_relate_to_clinical_practice) - [Should healthcare providers take action based on this news?](#Should_healthcare_providers_take_action_based_on_this_news) - [Related](#Related) ## FAQ #### What type of clinical relevance does this cannabis news have? This article has been assigned a Clinical Relevance rating of #70, indicating “Notable Clinical Interest.” It represents emerging findings or policy developments that are worth monitoring closely by healthcare professionals. #### What areas does this cannabis news cover? The article covers multiple important areas including policy changes, regulation updates, federal law developments, and clinical practice implications. These interconnected topics suggest comprehensive cannabis-related legislative or regulatory changes. #### Why is this news marked as “New”? The “New” designation indicates this is recent breaking news or updated information. This suggests the cannabis policy or regulatory developments discussed are current and may require immediate attention from clinicians and healthcare systems. #### How does this relate to clinical practice? The inclusion of “Clinical Practice” as a key topic suggests this news will directly impact how healthcare providers approach cannabis-related patient care. Changes in federal law and regulation often require updates to clinical protocols and patient management strategies. #### Should healthcare providers take action based on this news? Given the “Notable Clinical Interest” rating and policy/regulatory focus, healthcare providers should stay informed about these developments. Changes in federal cannabis law and regulation may require updates to practice guidelines, patient education, and compliance procedures. {“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Congressman Demands Marijuana Rescheduling Update From DOJ, Three Months After …”, “url”: “https://www.marijuanamoment.net/congressman-demands-marijuana-rescheduling-update-from-doj-three-months-after-trumps-executive-order/”, “datePublished”: “2026-03-27T17:43:33Z”, “about”: “congressman demands marijuana rescheduling update doj”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Trump advisor says someone is "holding up" cannabis rescheduling (Newsletter: April 10, 2026)](https://cedclinic.com/2026-cannabis-rescheduling-news-trump-advisor-delay/) Explore insights on delays in cannabis rescheduling from a Trump advisor's perspective and implications for federal policy. [Read More](https://cedclinic.com/2026-cannabis-rescheduling-news-trump-advisor-delay/) [Justice Department reclassifies state-licensed medical marijuana as a less dangerous drug](https://cedclinic.com/justice-department-medical-marijuana-reclassification/) Learn about the DOJ's recent reclassification of [medical marijuana](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) and its impact on federal cannabis regulation. [Learn More](https://cedclinic.com/justice-department-medical-marijuana-reclassification/) [Cannabis rescheduling testimony in Congress (Newsletter: April 7, 2026)](https://cedclinic.com/cannabis-rescheduling-testimony-congress-april-2026/) Review congressional testimony on cannabis rescheduling and ongoing legislative efforts shaping federal cannabis policy. [Explore Details](https://cedclinic.com/cannabis-rescheduling-testimony-congress-april-2026/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).